EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Advances in Hereditary Angioedema: Targets, Structures, and Molecules

Shangde Liu, Xue Song, Zhenyu Zhang, Tianlei Han, Xingsen Wu, Huabin Hu

Medicinal Research Reviews · 18.11.2026

DOI: 10.1002/med.70130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinal Research Reviews, online erschienen am 18.11.2026. Verfasst von Shangde Liu und 5 weiteren Autor:innen. Die Arbeit nennt 274 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Natural Science Foundation of Liaoning Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary angioedema (HAE) is a severe inherited disease characterized by unpredictable, recurrent swelling episodes driven by excessive bradykinin generation. As advances in structural biology and targeted therapeutic modalities have accumulated, HAE management has evolved from symptomatic suppression to mechanism‐based intervention, with current clinical strategies anchored in C1‐INH replacement, plasma kallikrein inhibition, factor XIIa blockade, and bradykinin B2 receptor antagonism. In this review, we provide a drug‐discovery perspective on the development of therapeutics targeting these validated targets. We summarize the major therapeutic modalities, including monoclonal antibodies, peptides, orally available small molecules, and nucleic‐acid‐based therapeutics, as well as strategies for developing long‐acting formulations. We also highlight how advances in structural biology, chemical‐space exploration, and developability optimization have guided the design and development of these therapeutics. Furthermore, we discuss potential targets beyond the canonical pathway, including contact‐system amplification nodes, bypass or noncanonical routes to bradykinin generation, and endothelial barrier regulators, which may inform precision or combination strategies. Together, these perspectives broaden the therapeutic landscape and provide a rationale for the development of next‐generation HAE therapies.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Liu, S., Song, X., Zhang, Z., Han, T., Wu, X., & Hu, H. (2026). Therapeutic Advances in Hereditary Angioedema: Targets, Structures, and Molecules. Medicinal Research Reviews. https://doi.org/10.1002/med.70130

Vancouver

Liu S, Song X, Zhang Z, Han T, Wu X, Hu H. Therapeutic Advances in Hereditary Angioedema: Targets, Structures, and Molecules. Medicinal Research Reviews. 2026. doi:10.1002/med.70130

BibTeX
@article{Liu2026,
  author = {Liu, Shangde and Song, Xue and Zhang, Zhenyu and Han, Tianlei and Wu, Xingsen and Hu, Huabin},
  title = {Therapeutic Advances in Hereditary Angioedema: Targets, Structures, and Molecules},
  journal = {Medicinal Research Reviews},
  year = {2026},
  doi = {10.1002/med.70130}
}
Kostenlos starten →